Protection of heart tissue from reperfusion injury
US4877810A · kind A · utility
14Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 1988 |
| Grant date | Oct 31, 1989 |
| Priority date | — |
| Expiry date | Feb 5, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Administration of chroman, 6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid, prior to or simultaneously with resuming normal blood supply to the heart following ischemia provides substantial protection from tissue damage that otherwise is observed upon reperfusion of the heart.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.